Morgan Stanley’s Burning Rock Biotech BNR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$57.5K Buy
18,207
+7,481
+70% +$23.6K ﹤0.01% 6311
2025
Q1
$48.3K Hold
10,726
﹤0.01% 6276
2024
Q4
$72.4K Buy
10,726
+300
+3% +$2.03K ﹤0.01% 6176
2024
Q3
$34K Sell
10,426
-5,557
-35% -$18.1K ﹤0.01% 6330
2024
Q2
$103K Sell
15,983
-6,405
-29% -$41.3K ﹤0.01% 5953
2024
Q1
$163K Sell
22,388
-41,574
-65% -$303K ﹤0.01% 5792
2023
Q4
$595K Buy
63,962
+31,974
+100% +$297K ﹤0.01% 5550
2023
Q3
$310K Sell
31,988
-31,385
-50% -$304K ﹤0.01% 5381
2023
Q2
$1.36M Sell
63,373
-13,992
-18% -$301K ﹤0.01% 4646
2023
Q1
$2.17M Sell
77,365
-13,836
-15% -$389K ﹤0.01% 4415
2022
Q4
$2.05M Sell
91,201
-298
-0.3% -$6.71K ﹤0.01% 4445
2022
Q3
$2.19M Sell
91,499
-5,921
-6% -$142K ﹤0.01% 4365
2022
Q2
$2.83M Buy
97,420
+8,839
+10% +$257K ﹤0.01% 4261
2022
Q1
$8.23M Buy
88,581
+36,109
+69% +$3.35M ﹤0.01% 3136
2021
Q4
$5M Buy
52,472
+5,708
+12% +$544K ﹤0.01% 3718
2021
Q3
$8.36M Buy
46,764
+31,065
+198% +$5.55M ﹤0.01% 3103
2021
Q2
$4.63M Buy
15,699
+15,579
+12,983% +$4.59M ﹤0.01% 3863
2021
Q1
$32K Sell
120
-634
-84% -$169K ﹤0.01% 6553
2020
Q4
$174K Buy
754
+393
+109% +$90.7K ﹤0.01% 5660
2020
Q3
$90K Buy
361
+280
+346% +$69.8K ﹤0.01% 5472
2020
Q2
$22K Buy
+81
New +$22K ﹤0.01% 5979